Methamnetamine
Methamnetamine (also known as MNA or N-methyl-2-AI) is a psychoactive drug and research chemical that is structurally related to methamphetamine and 2-AI. It is known for its stimulant effects, which are similar to those of other amphetamine-like substances.
History[edit]
Methamnetamine was first synthesized in the early 21st century as part of a wave of new psychoactive substances. It was initially sold online as a "legal high" or "research chemical," often marketed as an alternative to illegal stimulants like methamphetamine or MDMA.
Pharmacology[edit]
Methamnetamine is a monoamine releasing agent, meaning it increases the levels of certain chemicals in the brain. Specifically, it is thought to increase the levels of dopamine, norepinephrine, and serotonin, which are neurotransmitters associated with feelings of pleasure, energy, and mood regulation.
Effects[edit]
The effects of methamnetamine can vary widely depending on the dose, the individual's physiology, and the context in which it is used. Common effects reported by users include increased energy, euphoria, increased sociability, and heightened sensory perception. However, it can also cause negative effects such as anxiety, paranoia, and physical discomfort.
Legal Status[edit]
The legal status of methamnetamine varies by country. In some places, it is classified as a controlled substance, while in others it is legal to possess and use. It is important to note that even in places where it is legal, it may still be associated with significant health risks.
Health Risks[edit]
Like other stimulants, methamnetamine can put a significant strain on the heart and circulatory system. It can also cause psychological effects such as anxiety and paranoia, and in some cases, it may trigger a psychotic episode. Long-term use can lead to dependence and addiction.
See Also[edit]
This article is a Psychoactive substance-related stub. You can help WikiMD by expanding it!
-
Methamnetamine
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
